{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:58:25Z","timestamp":1783637905739,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jdmv.2021.03.008","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:13:00Z","timestamp":1618963980000},"page":"129-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population"],"prefix":"10.1016","volume":"46","author":[{"given":"S.","family":"Taharboucht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Guermaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chibane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdmv.2021.03.008_bib0345","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0350","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.08.010","article-title":"Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans","volume":"14","author":"Kanwal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0360","first-page":"9","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0365","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jceh.2019.09.005","article-title":"Natural History of Simple Steatosis or Nonalcoholic Fatty Liver","volume":"10","author":"De","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0370","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0375","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cld.2015.10.004","article-title":"Extrahepatic Complications of Nonalcoholic Fatty Liver Disease","volume":"20","author":"Chacko","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0380","doi-asserted-by":"crossref","first-page":"483135","DOI":"10.1155\/2012\/483135","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?","volume":"2012","author":"Ahmed","year":"2012","journal-title":"J Obes"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0385","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.metabol.2015.09.017","article-title":"Non-alcoholic fatty liver disease and risk of cardiovascular disease","volume":"65","author":"Lonardo","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0390","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0395","first-page":"544","article-title":"Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?","volume":"34","author":"Targher","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0400","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0405","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0410","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/ajg.2012.331","article-title":"Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease","volume":"107","author":"Wong","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0415","series-title":"Marqueurs non-invasifs de st\u00e9atose et Fibrose h\u00e9patique. [Physiologie et Physiopathologie]","author":"Barbosa","year":"2014"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0420","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0425","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.echo.2008.09.009","article-title":"American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography","volume":"21","author":"Mulvagh","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0430","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0435","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0440","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"consensus worldwide definition of the metabolic syndrome","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0445","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0450","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehq165","article-title":"Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: \u201cestablishing normal and reference values\u201d","volume":"31","author":"Boutouyrie","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0455","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vascular Endovasc Surg"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0460","series-title":"Mesure de la rigidit\u00e9 art\u00e9rielle","author":"Laurent","year":"2013"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0465","first-page":"3","article-title":"Arterial Stiffness: Recommendations and Standardization","volume":"4","author":"Townsend","year":"2017","journal-title":"Pulse (Basel, Switzerland)"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0470","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjmed.2007.08.041","article-title":"Carotid artery intima-media thickness in nonalcoholic fatty liver disease","volume":"121","author":"Fracanzani","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0475","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0480","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0021-9150(00)00529-3","article-title":"Additive impacts of diabetes and renal failure on carotid atherosclerosis","volume":"153","author":"Shoji","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0485","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1681\/ASN.V12112458","article-title":"Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients","volume":"12","author":"Benedetto","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0490","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.ATV.0000160613.57985.18","article-title":"Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study","volume":"25","author":"Brea","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0495","first-page":"7673","article-title":"Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis","volume":"8","author":"Cai","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0500","first-page":"661","article-title":"Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease","volume":"7","author":"Mohammadi","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0505","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.2337\/diacare.27.10.2498","article-title":"Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation","volume":"27","author":"Targher","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0510","series-title":"Enqu\u00eate nationale sur la mesure du poids des facteurs de risque des Maladies Non Transmissibles selon l\u2019approche STEPwise de l\u2019OMS. Principaux r\u00e9sultats","year":"2018"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0515","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0261-5614(99)80015-6","article-title":"Non-alcoholic fatty liver: another feature of the metabolic syndrome?","volume":"18","author":"Cortez-Pinto","year":"1999","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0520","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0525","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40292-016-0139-2","article-title":"Global Cardiovascular Risk Assessment: Strengths and Limitations","volume":"23","author":"Redon","year":"2016","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0530","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4250\/jcu.2012.20.3.126","article-title":"Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients","volume":"20","author":"Kang","year":"2012","journal-title":"J Cardiovasc Ultrasound"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0535","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0021-9150(99)00276-2","article-title":"Distribution of ultrasonographically-assessed dimensions of common carotid arteries in healthy adults of both sexes","volume":"148","author":"Denari\u00e9","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0540","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004872-200202000-00001","article-title":"Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk","volume":"20","author":"Simon","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0545","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2013.09.063","article-title":"Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective\u00a0observational data from 17,635 subjects","volume":"63","author":"Ben-Shlomo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0550","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0555","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/HJH.0b013e32833a7de6","article-title":"Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study","volume":"28","author":"Salvi","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0560","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/liv.14322","article-title":"Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score","volume":"40","author":"Xin","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0565","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2015.05.002","article-title":"Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease","volume":"241","author":"Chen","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0570","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/liv.14274","article-title":"Liver fibrosis by FibroScan((R)) independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes","volume":"40","author":"Lombardi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0575","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2014.10.004","article-title":"Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness","volume":"237","author":"Sunbul","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0580","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jash.2014.03.002","article-title":"Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease","volume":"8","author":"Omelchenko","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0585","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2014.09.011","article-title":"Inflammation and arterial stiffness in humans\u201d","volume":"237","author":"Jain","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.jdmv.2021.03.008_bib0590","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.3748\/wjg.v20.i37.13306","article-title":"Nonalcoholic fatty liver disease and vascular disease: state-of-the-art","volume":"20","author":"Fargion","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0595","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/ijms17040460","article-title":"NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?","volume":"17","author":"Villela-Nogueira","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0600","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-159-5-201309030-00007","article-title":"The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"159","author":"Lin","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0605","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/HJH.0b013e3283576faf","article-title":"High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults","volume":"30","author":"Vasunta","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0610","article-title":"NAFLD and cardiovascular diseases: a clinical review","author":"Kasper","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0615","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","article-title":"Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase","volume":"23","author":"L\u00f3pez-Su\u00e1rez","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0620","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/HJH.0000000000001245","article-title":"Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease","volume":"35","author":"Lorbeer","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0625","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/HJH.0b013e32833c211b","article-title":"The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study","volume":"28","author":"Lau","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0630","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/HJH.0000000000000532","article-title":"Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk","volume":"33","author":"Aneni","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0635","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/HYPERTENSIONAHA.120.15220","article-title":"Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories","volume":"76","author":"Ciardullo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0640","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.31014","article-title":"Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0650","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11883-003-0004-3","article-title":"C-reactive protein and risk of cardiovascular disease: Evidence and clinical application","volume":"5","author":"Ridker","year":"2003","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0655","doi-asserted-by":"crossref","first-page":"971453","DOI":"10.1155\/2015\/971453","article-title":"Emerging risk biomarkers in cardiovascular diseases and disorders","volume":"2015","author":"Upadhyay","year":"2015","journal-title":"J Lipids"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0660","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacc.2015.10.058","article-title":"Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment","volume":"67","author":"Yeboah","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0665","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2014.06.006","article-title":"Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies","volume":"236","author":"Kunutsor","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0670","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.atherosclerosis.2008.01.019","article-title":"The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes","volume":"201","author":"Wannamethee","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0675","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/2230-8210.163172","article-title":"Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes","volume":"19","author":"Sanyal","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jdmv.2021.03.008_bib0680","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12072-013-9446-z","article-title":"Current histological classification of NAFLD: strength and limitations","volume":"7","author":"Bedossa","year":"2013","journal-title":"Hepatol Int"}],"container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451321000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542451321000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:05:59Z","timestamp":1762869959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542451321000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2542451321000547"],"URL":"https:\/\/doi.org\/10.1016\/j.jdmv.2021.03.008","relation":{},"ISSN":["2542-4513"],"issn-type":[{"value":"2542-4513","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population","name":"articletitle","label":"Article Title"},{"value":"JMV-Journal de M\u00e9decine Vasculaire","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdmv.2021.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}